Literature DB >> 12131556

Ca2+ entry channels involved in contractions of rat aorta induced by endothelin-1, noradrenaline, and vasopressin.

Hidekatsu Furutani1, Xiao-Feng Zhang, Yasushi Iwamuro, Ken Lee, Yasuo Okamoto, Osamu Takikawa, Mitsuhiro Fukao, Tomoh Masaki, Soichi Miwa.   

Abstract

Endothelin-1 (ET-1) has been shown to activate three types of Ca2+ channel, namely two Ca2+-permeable nonselective cation channels (designated NSCC-1 and NSCC-2) and a store-operated Ca2+ channel (SOCC), and that these channels can be discriminated by Ca2+ channel blockers such as LOE 908 (a blocker of NSCC-1 and NSCC-2) and SK&F 96365 (a blocker of NSCC-2 and SOCC). This study pharmacologically compared Ca2+ entry channels involved in contractions of rat thoracic aorta without endothelium induced by ET-1, noradrenaline (NA), or arginine-vasopressin (AVP). These agonists-induced contractions of aortic rings without endothelium and increases in the intracellular free Ca2+ concentration ([Ca2+]i) of cultured aortic smooth muscle cells were abolished by removal of extracellular Ca2+. A blocker of L-type voltage-operated Ca2+ channel (VOCC), nifedipine had no effect on the responses to ET-1, but it suppressed the responses to NA and AVP to 70% and 65% of control responses, respectively. LOE 908 partially suppressed the nifedipine-resistant responses to ET-1 and AVP, but not those to NA. SK&F 96365 also partially suppressed the nifedipine-resistant responses to ET-1 and AVP, whereas it abolished the responses to NA. LOE 908 in combination with SK&F 96365 abolished the nifedipine-resistant responses to either of the agonists. These results show that the contraction of rat aorta involves different Ca2+ entry channel depending on agonists: (a) NSCC-1, NSCC-2, and SOCC for ET-1; (b) VOCC and SOCC for NA; and (c) VOCC, NSCC-1, NSCC-2, and SOCC for AVP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12131556     DOI: 10.1097/00005344-200208000-00012

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects.

Authors:  Takumi Sakurada; Keisuke Ishizawa; Masaki Imanishi; Yuki Izawa-Ishizawa; Shoko Fujii; Erika Tominaga; Teppei Tsuneishi; Yuya Horinouchi; Yoshitaka Kihira; Yasumasa Ikeda; Shuhei Tomita; Ken-ichi Aihara; Kazuo Minakuchi; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-14       Impact factor: 3.000

2.  Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries.

Authors:  Vladimir A Snetkov; Gregory A Knock; Lynne Baxter; Gavin D Thomas; Jeremy P T Ward; Philip I Aaronson
Journal:  J Physiol       Date:  2005-12-15       Impact factor: 5.182

3.  Cholesterol depletion alters coronary artery myocyte Ca(2+) signalling in a stimulus-specific manner.

Authors:  Clodagh Prendergast; John Quayle; Theodor Burdyga; Susan Wray
Journal:  Cell Calcium       Date:  2010-01       Impact factor: 6.817

Review 4.  TRP channels in hypertension.

Authors:  Amy L Firth; Carmelle V Remillard; Jason X-J Yuan
Journal:  Biochim Biophys Acta       Date:  2007-03-01

5.  Alterations of voltage-dependent calcium channel currents in basilar artery smooth muscle cells at early stage of subarachnoid hemorrhage in a rabbit model.

Authors:  Xianqing Shi; Yongjian Fu; Daqing Liao; Yanfang Chen; Jin Liu
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.